Hugh M. Davis insider trades
Open-market stock purchases and sales by Hugh M. Davis, President and COO at Aclaris Therapeutics, Inc, from SEC Form 4 filings since Dec 2, 2024.
Companies traded
- ACRS Aclaris Therapeutics, Inc: other filings, last Feb 3, 2026